Beware of Investing in These 3 Small-Cap Coronavirus Stocks

Less than one year after the emergence of SARS-CoV-2, science has already developed a significant number of diagnostic tests, antibody tests, treatments, and experimental vaccines. The speed at which such innovations are being used against the virus is arguably unprecedented for any major global pandemic.

Because the pandemic is rapidly evolving, the companies that are part of the fight against the coronavirus are changing swiftly as well. More specifically, a number of hyped-up coronavirus ventures initiated by a few small-cap companies in the sector are looking increasingly likely to disappoint investors. Today, let's take a look at these companies and their efforts, and why it's a good idea to refrain from investing in each.

Image source: Getty Images.

Source Fool.com